[go: up one dir, main page]

UY26560A1 - ASYMMETRIC SYNTHESIS OF PREGABALIN - Google Patents

ASYMMETRIC SYNTHESIS OF PREGABALIN

Info

Publication number
UY26560A1
UY26560A1 UY26560A UY26560A UY26560A1 UY 26560 A1 UY26560 A1 UY 26560A1 UY 26560 A UY26560 A UY 26560A UY 26560 A UY26560 A UY 26560A UY 26560 A1 UY26560 A1 UY 26560A1
Authority
UY
Uruguay
Prior art keywords
pregabalin
asymmetric synthesis
provides
useful
seizures
Prior art date
Application number
UY26560A
Other languages
Spanish (es)
Inventor
Mark Joseph Burk
Om Prakash Goel
Marvin Simon Hoekstra
Thomas Frederick Mich
Thomas Arthur Mulhern
Janes Andrew Ransden
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to UY26560A priority Critical patent/UY26560A1/en
Publication of UY26560A1 publication Critical patent/UY26560A1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Este invento porporciona un método para preparar (S)-(+)-ácido 3-(aminometil)-5-metil-hexanoico (pregabalin) o una de sus sales por medio de una síntesis de hidrogenación asimétrica. El pregabalin es útil para el tratamiento y la prevención de trastornos causados por ataques (accesos), del dolor y trastornos psicóticos. El invento proporciona también compuestos intermedios útiles en la producción de pregabalin.This invention provides a method for preparing (S) - (+) - 3- (aminomethyl) -5-methyl-hexanoic acid (pregabalin) or one of its salts by means of an asymmetric hydrogenation synthesis. Pregabalin is useful for the treatment and prevention of disorders caused by seizures, pain and psychotic disorders. The invention also provides intermediates useful in the production of pregabalin.

UY26560A 2001-01-25 2001-01-25 ASYMMETRIC SYNTHESIS OF PREGABALIN UY26560A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26560A UY26560A1 (en) 2001-01-25 2001-01-25 ASYMMETRIC SYNTHESIS OF PREGABALIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26560A UY26560A1 (en) 2001-01-25 2001-01-25 ASYMMETRIC SYNTHESIS OF PREGABALIN

Publications (1)

Publication Number Publication Date
UY26560A1 true UY26560A1 (en) 2001-09-28

Family

ID=38812328

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26560A UY26560A1 (en) 2001-01-25 2001-01-25 ASYMMETRIC SYNTHESIS OF PREGABALIN

Country Status (1)

Country Link
UY (1) UY26560A1 (en)

Similar Documents

Publication Publication Date Title
CU23221A3 (en) ASYMMETRIC SYNTHESIS OF PREGABALIN
BRPI0606118A2 (en) an asymmetric synthesis of (-) - (+) -3- (aminomethyl) -5- methylhexanoic acid
DK1696931T3 (en) Amino-substituted diaryl [A, D] cyclohepten analogs as muscarinic agonists and methods for the treatment of neuropsychiatric disorders
HUS2100028I1 (en) ERBB type I receptor tyrosine kinase inhibitor N4-phenylquinazolin-4-amine derivatives and related compounds for the treatment of hyperproliferative diseases
DK1404324T3 (en) Preservatives of GABA analogues, compositions and uses thereof
ECSP066917A (en) ESTEROSELECTIVE BIOCONVERSION OF ALIFATIC DINITRILS IN CYANOCARBOXYLIC ACIDS
NO20050122L (en) Prodrug of excitation amino acids
NO20062663L (en) Nucleic acid that specifically binds bioactive ghrelin
BRPI0214821B8 (en) method to determine the responsiveness of an individual with a psychotic disorder to treatment with loperidone
UY26560A1 (en) ASYMMETRIC SYNTHESIS OF PREGABALIN
DE60325194D1 (en) METHODS OF USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES
ATE387425T1 (en) METHOD FOR PRODUCING BICALUTAMID
DE602006003204D1 (en) Purification method of moxonidine
ATE432005T1 (en) STUDS FOR HORSESHOES
GT200100017A (en) ASYMMETRIC SYNTHESIS OF PREGABALINE.
UY39820A (en) ONE-STEP PROCESS FOR THE PREPARATION OF A CHIRAL AMINO ACID
HUP0204460A2 (en) Method for increasing the gene expression of transfected genes
CU23562A3 (en) ESTEREOSELECTIVE BIOCONVERSION OF ALIFATIC DINITRILS IN CYANOCARBOXYLIC ACIDS
MX2007000042A (en) Method for producing enantiomeric form of 2, 3-diaminopropionic acid derivatives.
HN2002000132A (en) CHIRAL SALT RESOLUTION
SE0101257D0 (en) Treatment of whiplash associated disorder
UY29033A1 (en) AMINO ACIDS WITH AFFINITY FOR PROTEIN A2O (ALFA 2 DELTA)

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20131121

VENC Patent expired

Effective date: 20210125